You are here

retinopathy of prematurity

Regeneron secures priority review for Eylea's use in infant retinopathy

Fierce Pharma

Wed, 10/12/22 - 11:40 pm

retinopathy of prematurity

priority review

Bayer begins phase 3 trial testing aflibercept in infant blindness

Pharmaforum

Mon, 06/24/19 - 09:39 am

clinical trials

infant blindness

retinopathy of prematurity

Novartis plans to file for new Lucentis indication in ROP

Pharmaceutical Business Review

Mon, 09/24/18 - 09:39 am

retinopathy of prematurity